AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹800 Cr | ₹1,814 Cr | ₹-2,969 Cr | ₹-1,365 Cr | ₹-1,947 Cr |
What is the latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹800 Cr |
Mar2023 | ₹1,814 Cr |
Mar2022 | ₹-2,969 Cr |
Mar2021 | ₹-1,365 Cr |
Mar2020 | ₹-1,947 Cr |
How is Cash Flow from Financing Activities of AUROBINDO PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹800 Cr | -55.89 | |
Mar2023 | ₹1,814 Cr | Positive | |
Mar2022 | ₹-2,969 Cr | Negative | |
Mar2021 | ₹-1,365 Cr | Negative | |
Mar2020 | ₹-1,947 Cr | - |
Compare Cash Flow from Financing Activities of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹68,066.9 Cr | 10.9% | 7.1% | 4.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,394.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 10.9% |
7.1% |
4.2% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses